MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

06 Aug 2026 Evaluate
A decrease of about -71.29% in the sales to Rs. 4.43 millions was observed for the quarter ended June 2026. The sales stood at Rs. 15.43 millions during the similar quarter previous year.A radical decline of -83.57% was reported in the net profit of the company for the quarter ended June 2026 to Rs. 2.21  millions from Rs. 13.45 millions.The company reported a degrowth in operating Profit to 2.21 millions from 13.45 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 4.43 15.43 -71.29 4.43 15.43 -71.29 25.58 8.38 205.25
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 2.21 13.45 -83.57 2.21 13.45 -83.57 9.57 -2.93 -426.62
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 2.21 13.45 -83.57 2.21 13.45 -83.57 9.57 -2.93 -426.62
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 2.21 13.45 -83.57 2.21 13.45 -83.57 9.57 -2.93 -426.62
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.97 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 2.21 13.45 -83.57 2.21 13.45 -83.57 8.60 -2.93 -393.52
Equity 1053.04 902.60 16.67 1053.04 902.60 16.67 902.60 652.60 38.31
PBIDTM(%) 49.89 87.17 -42.77 49.89 87.17 -42.77 37.41 -34.96 -207.00
Peers